INTERCONNECTS

SAN DIEGO -- Genomatica, Inc., a leading in silico systems biology company, today announced that Christophe Schilling, Ph.D., Vice President and Chief Technology Officer, has been named to the 2003 list of the world's 100 Top Young Innovators by Technology Review, MIT's Magazine of Innovation. The TR100, chosen by the editors of Technology Review and an elite panel of judges, consists of 100 individuals under age 35 whose innovative work in technology has a profound impact on today's world. Nominees are recognized for their contributions in transforming the nature of technology in industries such as biotechnology, computing, energy, medicine, manufacturing, nanotechnology, telecommunications and transportation. In November 1998, Dr. Schilling co-founded Genomatica, Inc. with the bold vision of using modeling and simulation technology to transform the ways in which organisms are engineered and drug are discovered. Today Genomatica is one of the leading Systems Biology companies providing modeling solutions to both commercial and academic settings for a wide array of problems across both medical and industrial biotechnology. Genomatica has a number of major corporate partnerships with leading chemical and biotechnology companies and has been awarded numerous government grants, including two Phase II SBIRs recently granted by the National Institutes of Health and the Department of Energy. In 2000, Dr. Schilling received his doctoral degree from the Bioengineering Department at the University of California, San Diego, during which time he was a Whitaker Foundation Fellow, and also holds a bachelor's degree in Biomedical Engineering from Duke University where he was a Howard Hughes Undergraduate Research Fellow. He is the chief scientific architect of the company's flagship modeling platform, SimPheny(TM), and the driving force behind the company's strategic business plan and commercialization efforts that have generated over seven million dollars in both equity financing and revenue since the Company's inception. He is a co-author of a number of scientific articles in the area of systems biology and metabolic engineering, and an inventor on a number of patent filings surrounding the Company's core technologies. In February 2001, he was named as one of 16 young 'up and comers' in the field of Genomics by Genome Technology. Currently, he is also the principal investigator for a number of federal research grants from both the NIH and DOE. TR100's unparalleled panel of judges includes: * Vinton Cerf, WorldCom Corporation * David Tennenhouse, Intel * Dr. Gordon Bell, Microsoft * Christina Lampe-Onnerud, TIAX * Stephen Quake, California Institute of Technology * Rodney Brooks, MIT CSAIL * George Whitesides, Harvard University "Innovation and technological change are essential to worldwide economic growth. Now, more than ever, it's important to recognize that there is no one technology driving the next wave of success, but rather several that, when fused together, will create another era of significant change for our society. The members of this year's TR100 hail from fields such as nanotechnology, biotechnology, wireless, energy, computing and medicine. Each is actively developing the emerging technologies that we feel will profoundly impact our world in the century ahead," said Robert Buderi, editor-in-chief of Technology Review. Dr. Schilling will be honored September 24 - 25 at The Emerging Technologies Conference at MIT. The event features keynotes, panels and breakout discussions on the transformative technological innovations that have the potential to fuel new economic growth and dramatically change the future. Speakers include Michael Dell, Founder and CEO of Dell Computer Corporation; Jeffrey R. Immelt, Chairman of the Board and CEO of General Electric; Bob Metcalfe, Founder of 3Com Corporation and General Partner at Polaris Venture Partners; and Nathan Myhrvold, Ph.D., Managing Director of Intellectual Ventures and former CTO of Microsoft Corporation. More information on ETC2003 can be found at www.etc2003.com .